4Sight launches conference division
July 7, 2010Medical Communications, Sales and Marketing 4Sight, Performance Meetings, sales and marketing
UK pharma commercial services company 4Sight has launched a conference division. The Bracknell, UK-based firm’s Performance Meetings division will be …
European scrutiny of pharma patent deals to continue
July 6, 2010Sales and Marketing European Commission, competition, patents
Europe’s drug watchdog has served notice that it will keep up scrutiny of pharma patent settlements to ensure they are …
Bind Biosciences appoints Dr Ed Schnipper
July 6, 2010Manufacturing and Production, Research and Development Bind Bioscience, appointment, manufacturing and production, research and development
US biopharmaceutical company Bind Biosciences has appointed Dr Ed Schnipper as chief medical officer. Dr Schnipper joins the company with …
NICE set to block Herceptin for gastric cancer
July 6, 2010Sales and Marketing Herceptin, NICE, Roche, gastric cancer
NICE’s preliminary draft guidance has not approved Roche’s Herceptin for gastric cancer as it failed to show how far the …
NHS slow to tackle health inequalities
July 6, 2010NHS, NHS targets
The NHS has not moved quickly enough to tackle inequalities in life expectancy in areas with the worst health and …
More woe for Genzyme as shipping delays continue
July 6, 2010Manufacturing and Production Cerezyme, Fabrazyme, Gaucher, Genzyme, manufacturing compliance
Genzyme is expecting further delays in shipments of two key products as it struggles to bring its troubled Allston Landing …
Pharma manufacturing news in brief
July 6, 2010Manufacturing and Production BMS, Borregaard Synthesis, Colorcon, JHP Pharma, Saltigo, Sanofi-Aventis, Synthetech, Viropharma, univar
New capital investments from Sanofi-Aventis, Bristol-Myers Squibb, Viropharma and Colorcon head up this round-up of developments in the pharmaceutical manufacturing …
Digital Pharma: Big pharma’s iPhone apps (part two)
July 5, 2010Medical Communications, Research and Development, Sales and Marketing Apple, Digital Pharma blog, app, ipad, iphone
Part one of Big Pharma’s iPhone Apps covered apps produced by Pfizer, Merck & Co, GlaxoSmithKline, Sanofi-Aventis and Novartis and …
AstraZeneca collaborates on compound library
July 5, 2010Research and Development AstraZeneca, MRC
AstraZeneca and the UK’s Medical Research Council are to share access to their compounds to improve their efforts to find …
Margot James: Tories to ‘nudge’ change in NHS
July 5, 2010Medical Communications, Sales and Marketing NHS, government, pm society
Speaking to the industry for the first time since being elected as Conservative MP for Stourbridge at the recent General …
Lilly set to acquire Alnara Pharmaceuticals
July 5, 2010Research and Development, Sales and Marketing Alnara, Liprotamase, cystic fibrosis, enzyme replacement therapy, lilly
Lilly is to acquire US-based biotech firm Alnara and will take hold of its lead product Liprotamase for pancreatic enzyme …
Ovarian cancer trial boost for Avastin
July 5, 2010Research and Development Roche, avastin, ovarian cancer
Roche’s blockbuster oncology drug Avastin has met its primary endpoint of improving progression-free survival in women with ovarian cancer in …
Aptuit deal saves GSK’s R&D unit in Verona
July 5, 2010Manufacturing and Production, Research and Development Aptuit, GlaxoSmithKline, Italy
GlaxoSmithKline has sold off its medicines research facility in Verona, Italy, to contract research and manufacturing service group Aptuit in …
Duncan Learmouth to lead new GSK unit
July 5, 2010Sales and Marketing GlaxoSmithKline, appointment, em, market access, sales and marketing
GlaxoSmithKline has created a new business group dedicated to improving access to medicines in the world’s least developed countries. GSK’s …
European Court upholds AZ Losec judgement
July 2, 2010Sales and Marketing AstraZeneca, Losec, generics
The General Court of the EU has upheld the European Commission’s 2005 decision that AstraZeneca were guilty of blocking cheaper …
NICE thumbs up for Roche arthritis drug
July 2, 2010Sales and Marketing NICE, RoActemra, Roche
NICE has given preliminary approval to Roche’s RoActemra as an additional option for the treatment of moderate to severe rheumatoid …
New ABPI Code for 2011
July 2, 2010Medical Communications, Sales and Marketing ABPI, Code of Practice, nhs partnerships
New guidance on the way pharma companies should approach marketing themselves to doctors are among the key changes in a …
Digital Pharma: Big pharma’s iPhone apps (part one)
July 2, 2010Medical Communications, Research and Development, Sales and Marketing Apple, Digital Pharma blog, app, digital pharma, ipad, iphone
Most sectors of business have been eagerly eyeing, and responding to, the potential of Apple’s iPhone, and this year’s iPad …
Talking Point: Crisis Management
July 2, 2010Medical Communications Crisis, Resolute, Talking Point
Crisis (noun): a situation that has reached an extremely difficult or dangerous point; a time of great disagreement, uncertainty or …
Buoyant growth forecast for contract manufacturing sector
July 2, 2010Manufacturing and Production contract manufacturing, manufacturing
Pharmaceutical contract manufacturing is heading for a period of strong growth as drugmakers continue to outsource production to improve efficiency, …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
